HIV Screening Among People Ages 55, Older Worthwhile, Study Finds

Main Category: HIV / AIDS
Also Included In: Seniors / Aging
Article Date: 19 Jun 2008 - 11:00 PDT

email to a friend   printer friendly   opinions  

Screening for HIV/AIDS among people ages 55 and older is worthwhile in terms of the potential savings in health care costs and the years of life gained from early detection, according to a study published Tuesday in the Annals of Internal Medicine, Reuters Health reports. CDC guidelines recommend routine HIV screening for people between ages 13 and 64.

For the study, Gillian Sanders of Duke University and colleagues calculated the cost of HIV screening and counseling among people age 65 to determine the costs and benefits of screening among people ages 55 to 75. According to the study, the costs and benefits of HIV screening depend on the total expense of testing and counseling, prevalence of the disease in the community, likelihood of transmission and the potential benefits when the disease is caught early. The study found that the cost of screening a person age 65 would be less than $60,000 for every "quality-adjusted life-year saved," even in areas where one in 1,000 people is HIV-positive, Reuters Health reports.

According to the researchers, the cost-benefit ratio compares favorably with other interventions that are considered worthwhile. "Advanced age alone should not preclude screening for HIV," the researchers said, concluding, "Rather, for many people in this age group, the cost-effectiveness of screening is within the range of that of other accepted interventions" (Reuters Health, 6/16).

The study is available online.

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

• Additional
• References
• Citations